Acadian Asset Management
TENX icon

Acadian Asset Management’s Tenax Therapeutics TENX Stock Holding History

Acadian Asset Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71K Buy
+4,502
New +$60.9K ﹤0.01% 1810
2023
Q1 		– Sell
-756
Closed -$133K – 1973
2022
Q4 		$133K Buy
+756
New +$166K ﹤0.01% 1374

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Acadian Asset Management's TENX Position: Q1 2026 in Review

Acadian Asset Management opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 4,502 shares worth $71K. The stake represents ﹤0.01% of the portfolio and ranks #1810 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in TENX as recently as Q4 2022.

Acadian Asset Management first reported a position in TENX in Q4 2022 and has held it in 2 quarters since. The position peaked at $133K in Q4 2022. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Acadian Asset Management held 4,502 shares of Tenax Therapeutics worth $71K as of Q1 2026.
  • Tenax Therapeutics was a new Acadian Asset Management position in Q1 2026.
  • Tenax Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1810 holding.
  • Acadian Asset Management first reported a position in Tenax Therapeutics in Q4 2022 and has held it in 2 quarters since.
  • Acadian Asset Management's Tenax Therapeutics position peaked at $133K in Q4 2022.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.